Endometrial ablation with the NovaSure system in Iran.


OBJECTIVE To evaluate the rate of response to treatment with the NovaSure endometrial ablation device among Iranian women with menorrhagia. METHODS Twenty 35-50-year-old women with menorrhagia who were referred to Arash Hospital, Tehran, Iran, in 2008 were enrolled. They underwent endometrial ablation via the NovaSure system and were followed-up for 2 years. RESULTS The incidence of amenorrhea was 30.0% at the end of the 2-year follow-up period. Hypomenorrhea was reported by 40.0% of women. The mean number of days of bleeding per month decreased significantly, from 30.0 ± 6.4 days before treatment to 3.1 ± 2.6 days after 2 years (P < 0.001). The severity of bleeding decreased significantly within 2 years after treatment (P < 0.001). In total, 85.0% of women were satisfied and 90.0% had responded to treatment-as defined by amenorrhea, hypomenorrhea, or return to normal menstruation. CONCLUSION The NovaSure system is effective and should be considered by gynecologists for the treatment of menorrhagia.


0 Figures and Tables

    Download Full PDF Version (Non-Commercial Use)